Showing results (1-10 of 124) with videos related to
Sort By:
Pageof 13
Current Opinion in Urology|August 9, 2001
New chemotherapy combinations for advanced bladder cancerJ Bellmunt, S AlbiolCritical Reviews in Oncology/Hematology|July 22, 2008
Optimizing therapeutic strategies in advanced bladder cancer: update on chemotherapy and the role of targeted agentsJ Bellmunt, S Albiol, C Suárez, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Gemcitabine in the treatment of advanced transitional cell carcinoma of the urotheliumJ Bellmunt, S Albiol, A Ramírez de Olano, et al.Critical Reviews in Oncology/Hematology|August 6, 2003
New drugs and new approaches in metastatic bladder cancerJ Bellmunt, R de Wit, S Albiol, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2009
Future developments in renal cell carcinomaJ BellmuntEuropean Urology|August 16, 2002
Bone alkaline phosphatase serum level predicts the response to antiandrogen withdrawalJ Morote, J BellmuntAmerican Journal of Clinical Oncology|January 1, 1991
European early phase II dose-finding study of droloxifene in advanced breast cancerJ Bellmunt, L SoléAnnals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2013
Targeted therapies and the treatment of non-clear cell renal cell carcinomaJ Bellmunt, J DutcherAnnals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
New agents for bladder cancerJ Bellmunt, M GuixAnnals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2007
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapyJ Bellmunt, L Paz-Ares, M Cuello, et al.Pageof 13